Key characteristics of carcinogens as a basis for organizing data on mechanisms of carcinogenesis

Environmental Health Perspectives

Volumn 124, Issue 6, 2016, Pages 713-721

  Smith, Martyn T ^a   Guyton, Kathryn Z ^b   Gibbons, Catherine F ^c   Fritz, Jason M ^c   Portier, Christopher J ^d   Rusyn, Ivan ^e   DeMarini, David M ^c   Caldwell, Jane C ^c   Kavlock, Robert J ^c   Lambert, Paul F ^f   Hecht, Stephen S ^g   Bucher, John R ^h   Stewart, Bernard W ⁱ   Baan, Robert A ^b   Cogliano, Vincent J ^c   Straif, Kurt ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^d ENVIRONMENTAL DEFENSE FUND   (United States)

^e TEXAS A AND M UNIVERSITY   (United States)

^f UNIVERSITY OF WISCONSIN MADISON   (United States)

^g UNIVERSITY OF MINNESOTA   (United States)

^h NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

ⁱ UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BENZENE; CARCINOGEN; POLYCHLORINATED BIPHENYL;

APOPTOSIS; CARCINOGENESIS; CELL IMMORTALIZATION; CELL PROLIFERATION; CHRONIC INFLAMMATION; DNA REPAIR; ELECTROPHILICITY; ENVIRONMENTAL EXPOSURE; EPIGENETICS; GENOMIC INSTABILITY; GENOTOXICITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; NUTRIENT SUPPLY; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; ANIMAL; CARCINOGEN TESTING; PROCEDURES; STANDARDS;

ANIMALS; BENZENE; CARCINOGENESIS; CARCINOGENICITY TESTS; CARCINOGENS; HUMANS; POLYCHLORINATED BIPHENYLS; RISK ASSESSMENT;

EID: 84971510313     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1509912     Document Type: Review

References (73)

1. Allday MJ. 2013. EBV finds a polycomb-mediated, epigenetic solution to the problem of oncogenic stress responses triggered by infection. Front Genet 4: 212, doi: 10. 3389/fgene. 2013. 00212.
2. Arana ME, Kunkel TA. 2010. Mutator phenotypes due to DNA replication infidelity. Semin Cancer Biol 20: 304-311.
3. Aranda A, Pascual A. 2001. Nuclear hormone receptors and gene expression. Physiol Rev 81: 1269-1304.
4. Baek SH, Kim KI. 2014. Emerging roles of orphan nuclear receptors in cancer. Annu Rev Physiol 76: 177-195.
5. Batal M, Boudry I, Mouret S, Cléry-Barraud C, Wartelle J, Bérard I, et al. 2014. DNA damage in internal organs after cutaneous exposure to sulphur mustard. Toxicol Appl Pharmacol 278: 39-44.
6. Berquist BR, Wilson DM III. 2012. Pathways for repairing and tolerating the spectrum of oxidative DNA lesions. Cancer Lett 327: 61-72.
7. Bhattacharjee P, Banerjee M, Giri AK. 2013. Role of genomic instability in arsenic-induced carcinogenicity. A review. Environ Int 53: 29-40.
8. Bielas JH, Loeb KR, Rubin BP, True LD, Loeb LA. 2006. Human cancers express a mutator phenotype. Proc Natl Acad Sci USA 103: 18238-18242.
9. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, et al. 2009. A review of human carcinogens-Part B: biological agents. Lancet Oncol 10: 321-322.
10. Candéias S, Pons B, Viau M, Caillat S, Sauvaigo S. 2010. Direct inhibition of excision/synthesis DNA repair activities by cadmium: analysis on dedicated biochips. Mutat Res 694: 53-59.
11. Chappell G, Pogribny IP, Guyton KZ, Rusyn I. 2016. Epigenetic alterations induced by genotoxic occupational and environmental human chemical carcinogens: a systematic literature review. Mutat Res Rev Mutat Res 768: 27-45.
12. Chen SH, Oyarzabal EA, Hong JS. 2016. Critical role of the Mac1/NOX2 pathway in mediating reactive microgliosis-generated chronic neuroinflammation and progressive neurodegeneration. Curr Opin Pharmacol 26: 54-60.
13. Cogliano VJ, Baan R, Straif K, Grosse Y, LaubySecretan B, El Ghissassi F, et al. 2011. Preventable exposures associated with human cancers. J Natl Cancer Inst 103: 1827-1839.
14. Coussens LM, Pollard JW. 2011. Leukocytes in mammary development and cancer. Cold Spring Harb Perspect Biol 3: a003285, doi: 10. 1101/cshperspect. a003285.
15. Coussens LM, Zitvogel L, Palucka AK. 2013. Neutralizing tumor-promoting chronic inflammation: a magic bullet? Science 339: 286-291.
16. Ehrenberg L. 1984. Covalent binding of genotoxic agents to proteins and nucleic acids. IARC Sci Publ 59: 107-114.
17. Ehrenberg L, Brookes P, Druckrey H, Lagerlof B, Litwin J, Williams G. 1973. The relation of cancer induction and genetic damage. In: Evaluation of Genetic Risks of Environmental Chemicals, Report of Group 3, Ambio Special Report No. 3. Stockholm: Royal Swedish Academy of Sciences, Universitetsforlaget.
18. Figueira TR, Barros MH, Camargo AA, Castilho RF, Ferreira JC, Kowaltowski AJ, et al. 2013. Mitochondria as a source of reactive oxygen and nitrogen species: from molecular mechanisms to human health. Antioxid Redox Signal 18: 2029-2074.
19. Filipic M. 2012. Mechanisms of cadmium induced genomic instability. Mutat Res 733: 69-77.
20. Galluzzi L, Bravo-San Pedro JM, Vitale I, Aaronson SA, Abrams JM, Adam D, et al. 2015. Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell Death Differ 22: 58-73.
21. Goodson WH III, Lowe L, Carpenter DO, Gilbertson M, Manaf Ali A, Lopez de Cerain Salsamendi A, et al. 2015. Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead. Carcinogenesis 36(suppl 1): S254-S296.
22. Griner EM, Kazanietz MG. 2007. Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer 7: 281-294.
23. Grivennikov SI, Greten FR, Karin M. 2010. Immunity, inflammation, and cancer. Cell 140: 883-899.
24. Grosse Y, Baan R, Straif K, Secretan B, El Ghissassi F, Bouvard V, et al. 2007. Carcinogenicity of 1, 3-butadiene, ethylene oxide, vinyl chloride, vinyl fluoride, and vinyl bromide. Lancet Oncol 8: 679-680.
25. Guyton KZ, Kyle AD, Aubrecht J, Cogliano VJ, Eastmond DA, Jackson M, et al. 2009. Improving prediction of chemical carcinogenicity by considering multiple mechanisms and applying toxicogenomic approaches. Mutat Res 681: 230-240.
26. Guyton KZ, Loomis D, Grosse Y, El Ghissassi F, Benbrahim-Tallaa L, Guha N, et al. 2015. Carcinogenicity of tetrachlorvinphos, parathion, malathion, diazinon, and glyphosate. Lancet Oncol 16: 490-491.
27. Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: the next generation. Cell 144: 646-674.
28. Harris CC. 2015. Cause and prevention of human cancer [Editorial]. Carcinogenesis 36(suppl 1): S1.
29. Hartge P, Smith MT. 2007. Environmental and behavioral factors and the risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 16: 367-368.
30. Hecht SS. 2012. Lung carcinogenesis by tobacco smoke. Int J Cancer 131: 2724-2732.
31. Herceg Z, Lambert MP, van Veldhoven K, Demetriou C, Vineis P, Smith MT, et al. 2013. Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation. Carcinogenesis 34: 1955-1967.
32. Higgins JPT, Green S (eds). 2011. Cochrane Handbook for Systematic Reviews of Interventions. Version 5. 1. 0 (updated March 2011). Cochrane Collaboration.
33. Hu Z, Brooks SA, Dormoy V, Hsu CW, Hsu HY, Lin LT, et al. 2015. Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: focus on the cancer hallmark of tumor angiogenesis. Carcinogenesis 36(suppl 1): S184-S202.
34. IARC (International Agency for Research on Cancer). 2008. 1, 3-Butadiene, ethylene oxide and vinyl halides (vinyl fluoride, vinyl chloride and vinyl bromide). IARC Monogr Eval Carcinog Risk Hum 97: 3-471.
35. IARC. 2015. Polychlorinated biphenyls and polybrominated biphenyls. IARC Monogr Eval Carcinog Risk Hum 107: 39-500.
36. Kadhim M, Salomaa S, Wright E, Hildebrandt G, Belyakov OV, Prise KM, et al. 2013. Non-targeted effects of ionising radiation-implications for low dose risk. Mutat Res 752: 84-98.
37. Kayama Y, Raaz U, Jagger A, Adam M, Schellinger IN, Sakamoto M, et al. 2015. Diabetic cardiovascular disease induced by oxidative stress. Int J Mol Sci 16: 25234-25263.
38. Klaunig JE, Wang Z, Pu X, Zhou S. 2011. Oxidative stress and oxidative damage in chemical carcinogenesis. Toxicol Appl Pharmacol 254: 86-99.
39. Kleinstreuer NC, Dix DJ, Houck KA, Kavlock RJ, Knudsen TB, Martin MT, et al. 2013. In vitro perturbations of targets in cancer hallmark processes predict rodent chemical carcinogenesis. Toxicol Sci 131(1): 40-55, doi: 10. 1093/toxsci/kfs285.
40. Klingelhutz AJ. 1999. The roles of telomeres and telomerase in cellular immortalization and the development of cancer. Anticancer Res 19: 4823-4830.
41. Koustas E, Lam J, Sutton P, Johnson PI, Atchley DS, Sen S, et al. 2014. The Navigation Guide-evidence-based medicine meets environmental health: systematic review of nonhuman evidence for PFOA effects on fetal growth. Environ Health Perspect 122: 1015-1027, doi: 10. 1289/ehp. 1307177.
42. Kushman ME, Kraft AD, Guyton KZ, Chiu WA, Makris SL, Rusyn I. 2013. A systematic approach for identifying and presenting mechanistic evidence in human health assessments. Regul Toxicol Pharmacol 67: 266-277.
43. Lauby-Secretan B, Loomis D, Grosse Y, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, et al. 2013. Carcinogenicity of polychlorinated biphenyls and polybrominated biphenyls. Lancet Oncol 14: 287-288.
44. Loomis D, Guyton K, Grosse Y, El Ghissasi F, Bouvard V, Benbrahim-Tallaa L, et al. 2015. Carcinogenicity of lindane, DDT, and 2, 4-dichlorophenoxyacetic acid. Lancet Oncol 16: 891-892.
45. Luch A, Frey FC, Meier R, Fei J, Naegeli H. 2014. Low-dose formaldehyde delays DNA damage recognition and DNA excision repair in human cells. PloS One 9: e94149, doi: 10. 1371/journal. pone. 0094149.
46. Ma Q. 2011. Influence of light on aryl hydrocarbon receptor signaling and consequences in drug metabolism, physiology and disease. Expert Opin Drug Metab Toxicol 7: 1267-1293.
47. McHale CM, Zhang L, Smith MT. 2012. Current understanding of the mechanism of benzene-induced leukemia in humans: implications for risk assessment. Carcinogenesis 33: 240-252.
48. Miller JA. 1970. Carcinogenesis by chemicals: an overview-G. H. A. Clowes memorial lecture. Cancer Res 30: 559-576.
49. Multhoff G, Radons J. 2012. Radiation, inflammation, and immune responses in cancer. Front Oncol 2: 58, doi: 10. 3389/fonc. 2012. 00058.
50. NRC (National Research Council). 2014. Review of EPA's Integrated Risk Information System (IRIS) Process. Washington, DC: National Academies Press.
51. O'Brien PJ. 2000. Peroxidases. Chem Biol Interact 129: 113-139.
52. Pogribny IP, Rusyn I. 2013. Environmental toxicants, epigenetics, and cancer. Adv Exp Med Biol 754: 215-232.
53. Pollard JW. 2008. Macrophages define the invasive microenvironment in breast cancer. J Leukoc Biol 84: 623-630.
54. Preston BD, Albertson TM, Herr AJ. 2010. DNA replication fidelity and cancer. Semin Cancer Biol 20: 281-293.
55. Rafferty P, Egenolf D, Brosnan K, Makropoulos D, Jordan J, Meshaw K, et al. 2012. Immunotoxicologic effects of cyclosporine on tumor progression in models of squamous cell carcinoma and B-cell lymphoma in C3H mice. J Immunotoxicol 9: 43-55.
56. Rajendran JG, Mankoff DA, O'Sullivan F, Peterson LM, Schwartz DL, Conrad EU, et al. 2004. Hypoxia and glucose metabolism in malignant tumors: evaluation by [18 F]fluoromisonidazole and [18 F]fluorodeoxyglucose positron emission tomography imaging. Clin Cancer Res 10: 2245-2252.
57. Rooney AA, Boyles AL, Wolfe MS, Bucher JR, Thayer KA. 2014. Systematic review and evidence integration for literature-based environmental health science assessments. Environ Health Perspect 122: 711-718, doi: 10. 1289/ehp. 1307972.
58. Rushmore TH, Kong AN. 2002. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes. Curr Drug Metab 3: 481-490.
59. Rusyn I, Asakura S, Li Y, Kosyk O, Koc H, Nakamura J, et al. 2005. Effects of ethylene oxide and ethylene inhalation on DNA adducts, apurinic/apyrimidinic sites and expression of base excision DNA repair genes in rat brain, spleen, and liver. DNA Repair (Amst) 4: 1099-1110.
60. Ryter SW, Mizumura K, Choi AM. 2014. The impact of autophagy on cell death modalities. Int J Cell Biol 2014: 502676, doi: 10. 1155/2014/502676.
61. Saha A, Kaul R, Murakami M, Robertson ES. 2010. Tumor viruses and cancer biology: modulating signaling pathways for therapeutic intervention. Cancer Biol Ther 10: 961-978.
62. Salnikow K, Zhitkovich A. 2008. Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium. Chem Res Toxicol 21: 28-44.
63. Shaughnessy DT, DeMarini DM. 2009. Types and consequences of DNA damage. In: Chemoprevention of Cancer and DNA Damage by Dietary Factors (Knasmüller S, DeMarini DM, Johnson I, Gerhäuser C, eds). Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA.
64. Slaga TJ, Fischer SM, Weeks CE, Klein-Szanto AJ. 1980. Multistage chemical carcinogenesis in mouse skin. Curr Probl Dermatol 10: 193-218.
65. Smith MT. 1996. The mechanism of benzene-induced leukemia: a hypothesis and speculations on the causes of leukemia. Environ Health Perspect 104(suppl 6): 1219-1225.
66. Smith MT, Skibola CF, Allan JM, Morgan GJ. 2004. Causal models of leukaemia and lymphoma. IARC Sci Publ 157: 373-392.
67. Suman S, Sharma PK, Rai G, Mishra S, Arora D, Gupta P, et al. 2015. Current perspectives of molecular pathways involved in chronic inflammation-mediated breast cancer. Biochem Biophys Res Commun, doi: 10. 1016/j. bbrc. 2015. 10. 133 [online 29 October 2015]
68. Thomas RS, Philbert MA, Auerbach SS, Wetmore BA, Devito MJ, Cote I, et al. 2013. Incorporating new technologies into toxicity testing and risk assessment: moving from 21st century vision to a datadriven framework. Toxicol Sci 136: 4-18.
69. Trinchieri G. 2012. Cancer and inflammation: an old intuition with rapidly evolving new concepts. Annu Rev Immunol 30: 677-706.
70. U. S. EPA (U. S. Environmental Protection Agency). 2014. Next Generation Risk Assessment: Incorporation of Recent Advances in Molecular, Computational, and Systems Biology. EPA/600/R-14/004. Washington, DC: U. S. EPA.
71. Wallace BD, Redinbo MR. 2013. Xenobiotic-sensing nuclear receptors involved in drug metabolism: a structural perspective. Drug Metab Rev 45: 79-100.
72. Westcott PMK, Halliwill KD, To MD, Rashid M, Rust AG, Keane TM, et al. 2015. The mutational landscapes of genetic and chemical models of Kras-driven lung cancer. Nature 517: 489-492.
73. Yugawa T, Kiyono T. 2009. Molecular mechanisms of cervical carcinogenesis by high-risk human papilloma viruses: novel functions of E6 and E7 oncoproteins. Rev Med Virol 19: 97-113